Seeing Is Believing

Currently out of the existing stock ratings of Shanshan Xu, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst Shanshan Xu, carries an average stock price target met ratio of 58.33% that have a potential upside of 24.73% achieved within 70 days.
Shanshan Xu’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BNTX, BioNTech SE at 09-May-2023.
Analyst best performing recommendations are on BNTX (BIONTECH SE).
The best stock recommendation documented was for BNTX (BIONTECH SE) at 8/2/2021. The price target of $400 was fulfilled within 2 days with a profit of $59.79 (17.57%) receiving and performance score of 87.87.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 11-Nov-2021
$140
$43.31 (44.79%)
$136
1 months 28 days ago
(10-Nov-2025)
14/38 (36.84%)
$34.93 (33.24%)
70
Hold
Since 16-Sep-2024
$120
$23.31 (24.11%)
$121
2 months 15 days ago
(23-Oct-2025)
11/14 (78.57%)
$15.25 (14.56%)
37
Buy
Since 24-Sep-2024
$131
$34.31 (35.48%)
$133
2 months 28 days ago
(10-Oct-2025)
2/7 (28.57%)
$28.94 (28.36%)
25
Buy
Since 11-Dec-2024
$150
$53.31 (55.13%)
$170
5 months 2 days ago
(05-Aug-2025)
0/2 (0%)
$38.93 (35.05%)
Buy
Since 28-Mar-2023
$134
$37.31 (38.59%)
$126
5 months 2 days ago
(05-Aug-2025)
7/16 (43.75%)
$22.93 (20.64%)
30
What Year was the first public recommendation made by Shanshan Xu?